[Verification Material] The Importance of Analyzing Culture Medium Components in iPS Cell Cultivation

Presenter: Matt McCree (Biotechnology Products, Product Line Manager, Nova Biomedical (USA)) We will introduce Nova's latest technology for the automation and scale-up of cell culture analysis. *This webinar will be delivered with Japanese narration. Click here ⇒ https://event.on24.com/wcc/r/3520669/79BDB8909539A9C7AD769381155892FB?partnerref=ipros We are also streaming other webinars related to cell culture environment analysis → https://www2.novabio.us/jp-biowebinar Nova Biomedical Corporation

I talked about the development status of gene-modified T cell therapy and the latest initiatives at Mie University. Dr. Tamaki's team has three key focuses in CAR cell therapy development: "strictly specific receptors (pMHC recognition)," "original activation constructs (targeting GITR)," and "next-generation cell adjustments (automated adjustment devices)." This is summarized with a detailed theoretical background, key equipment used, and actual measurement data. You can find more here ⇒ https://event.on24.com/wcc/r/3338170/31426FFE70961897BB5A449BAC0D7C35?partnerref=ipros Additionally, we are currently streaming webinars on cell culture environment analysis → https://www2.novabio.us/jp-biowebinar Nova Biomedical Corporation

**Webinar Title** Integration of ambr15 Cell Culture and BioProfile FLEX2 Cell Culture Environment Analysis Device: Enabling Cell Line Screening with Abundant Data **Speaker** Kymab Ltd., a UK-based antibody drug manufacturer (https://www.kymab.com/) Development Leader: Rahul Pradhan *Japanese narration* **Overview** A detailed presentation by the development leader of Kymab Ltd., a user of Nova Biomedical products, on the utilization of the BioProfile FLEX2 automated cell culture environment analysis device. **Release Date** March 26, 2021 (Friday) at 11:00 AM, available for on-demand viewing thereafter. **Recommended For** Pharmaceutical manufacturers/CMOs/CDMOs This webinar is highly recommended for those interested in online sampling and automation in cell culture. Watch the webinar here → https://www2.novabio.us/jp-biowebinar

The 20th Annual Meeting of the Japanese Society for Regenerative Medicine Co-hosted Academic Seminar 4 Date: March 12, 2021 (Friday) 12:30–13:20 Channel: CH-1 Live Streaming (On-demand streaming available later) Co-hosted by: Nova Biomedical Corporation Title: "Gene-Modified T Cell Therapy" Chair: Dr. Masahiro Kinooka Professor, Department of Bioengineering, Graduate School of Engineering, Osaka University Speaker: Dr. Hiroshi Tamaki Professor, Department of Personalized Cancer Immunotherapy, Graduate School of Medicine, Mie University Director, Mie University Center for Comprehensive Cancer Immunotherapy Research *Registration for the conference is required to view. Please check the conference website for details.